NEJM Reports on 2 New Drugs for Hepatitis C

Last week’s NEJM delivered an intriguing, imperfect article on a new approach to treating hepatitis C (HCV). The paper’s careful title, Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1, seems right. The analysis, with 17 authors listed, traces the response of 21 people with hepatitis C (HCV) who got two new anti-viral agents, with or […]

Posted in Academic Medicine, clinical trials, Infectious DiseaseTagged , , , , , , , , , 1 Comment on NEJM Reports on 2 New Drugs for Hepatitis C

A Note on ‘Trial by Twitter’ and Peer Review in 2012

Nature just published a feature: Trial by Twitter. The piece considers the predicament of researchers who may find themselves ill-prepared to deal with a barrage of unsolicited and immediate on-line “reviews” of their published work. The author of the Nature News piece, science journalist A. Mandavilli, does a great job covering the pros and cons of Twitter “comments” […]

Posted in Academic Medicine, Science, Social MediaTagged , , , , , , Leave a Comment on A Note on ‘Trial by Twitter’ and Peer Review in 2012

Some Articles I Authored A While Ago

This post, on my research in cancer immunology, is strangely personal. At one level, what follows is nothing more than a list, a narrative if you will, a sketch of a formative chunk of my career and personal history. I’ve wanted to put this out there (here) for quite a while, but couldn’t: It’s been […]

Posted in Academic Medicine, from the author, Life, Life as a DoctorTagged , , , , , , , , , , 2 Comments on Some Articles I Authored A While Ago
newsletter software